185 related articles for article (PubMed ID: 18265975)
1. Tracking cellular stress with labeled FMAU reflects changes in mitochondrial TK2.
Tehrani OS; Douglas KA; Lawhorn-Crews JM; Shields AF
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1480-8. PubMed ID: 18265975
[TBL] [Abstract][Full Text] [Related]
2. Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells.
Plotnik DA; Emerick LE; Krohn KA; Unadkat JD; Schwartz JL
J Nucl Med; 2010 Sep; 51(9):1464-71. PubMed ID: 20720049
[TBL] [Abstract][Full Text] [Related]
3. Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs.
Schwartz JL; Tamura Y; Jordan R; Grierson JR; Krohn KA
J Nucl Med; 2003 Dec; 44(12):2027-32. PubMed ID: 14660729
[TBL] [Abstract][Full Text] [Related]
4. 18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers.
Buursma AR; Rutgers V; Hospers GA; Mulder NH; Vaalburg W; de Vries EF
Nucl Med Commun; 2006 Jan; 27(1):25-30. PubMed ID: 16340720
[TBL] [Abstract][Full Text] [Related]
5. Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents:
McHugh CI; Lawhorn-Crews JM; Modi D; Douglas KA; Jones SK; Mangner TJ; Collins JM; Shields AF
Cancer Imaging; 2016 Oct; 16(1):34. PubMed ID: 27751167
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity.
Wang J; Eriksson S
Antimicrob Agents Chemother; 1996 Jun; 40(6):1555-7. PubMed ID: 8726039
[TBL] [Abstract][Full Text] [Related]
7. Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer.
Sun H; Sloan A; Mangner TJ; Vaishampayan U; Muzik O; Collins JM; Douglas K; Shields AF
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):15-22. PubMed ID: 15586282
[TBL] [Abstract][Full Text] [Related]
8. Tumor imaging using 1-(2'-deoxy-2'-18F-fluoro-beta-D-arabinofuranosyl)thymine and PET.
Tehrani OS; Muzik O; Heilbrun LK; Douglas KA; Lawhorn-Crews JM; Sun H; Mangner TJ; Shields AF
J Nucl Med; 2007 Sep; 48(9):1436-41. PubMed ID: 17785728
[TBL] [Abstract][Full Text] [Related]
9. Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe.
Campbell DO; Yaghoubi SS; Su Y; Lee JT; Auerbach MS; Herschman H; Satyamurthy N; Czernin J; Lavie A; Radu CG
J Biol Chem; 2012 Jan; 287(1):446-454. PubMed ID: 22074768
[TBL] [Abstract][Full Text] [Related]
10. Rat studies comparing 11C-FMAU, 18F-FLT, and 76Br-BFU as proliferation markers.
Lu L; Samuelsson L; Bergström M; Sato K; Fasth KJ; Långström B
J Nucl Med; 2002 Dec; 43(12):1688-98. PubMed ID: 12468521
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT.
Nishii R; Volgin AY; Mawlawi O; Mukhopadhyay U; Pal A; Bornmann W; Gelovani JG; Alauddin MM
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):990-8. PubMed ID: 18057932
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation status of thymidine kinase 1 following antiproliferative drug treatment mediates 3'-deoxy-3'-[18F]-fluorothymidine cellular retention.
Sala R; Nguyen QD; Patel CB; Mann D; Steinke JH; Vilar R; Aboagye EO
PLoS One; 2014; 9(7):e101366. PubMed ID: 25003822
[TBL] [Abstract][Full Text] [Related]
13. Imaging DNA synthesis in vivo with 18F-FMAU and PET.
Sun H; Mangner TJ; Collins JM; Muzik O; Douglas K; Shields AF
J Nucl Med; 2005 Feb; 46(2):292-6. PubMed ID: 15695789
[TBL] [Abstract][Full Text] [Related]
14. Bromovinyl-deoxyuridine: A selective substrate for mitochondrial thymidine kinase in cell extracts.
Franzolin E; Rampazzo C; Pérez-Pérez MJ; Hernández AI; Balzarini J; Bianchi V
Biochem Biophys Res Commun; 2006 May; 344(1):30-6. PubMed ID: 16630572
[TBL] [Abstract][Full Text] [Related]
15. Imaging of cell proliferation: status and prospects.
Bading JR; Shields AF
J Nucl Med; 2008 Jun; 49 Suppl 2():64S-80S. PubMed ID: 18523066
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats.
Bading JR; Shahinian AH; Vail A; Bathija P; Koszalka GW; Koda RT; Alauddin MM; Fissekis JD; Conti PS
Nucl Med Biol; 2004 May; 31(4):407-18. PubMed ID: 15093810
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled 2'-fluorodeoxyuracil-beta-D-arabinofuranoside (FAU) and 2'-fluoro-5-methyldeoxyuracil-beta -D-arabinofuranoside (FMAU) as tumor-imaging agents in mice.
Wang H; Oliver P; Nan L; Wang S; Wang Z; Rhie JK; Zhang R; Hill DL
Cancer Chemother Pharmacol; 2002 May; 49(5):419-24. PubMed ID: 11976837
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
